Status:
ACTIVE_NOT_RECRUITING
Amyotrophic Lateral Sclerosis: A Multicenter Retrospective Observational Registry
Lead Sponsor:
Biocells Medical
Conditions:
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis &Amp; Other Neuromuscular Disorders
Eligibility:
All Genders
18-70 years
Brief Summary
This retrospective observational study will analyze de-identified clinical data from patients with amyotrophic lateral sclerosis (ALS) collected at multiple centers over 7 years. The primary objective...
Eligibility Criteria
Inclusion
- Diagnosis of amyotrophic lateral sclerosis (ALS) or motor neuron disease confirmed.
- Age ≥18 years.
- Availability of at least one ALS Functional Rating Scale-Revised (ALSFRS-R) score.
- Availability of longitudinal follow-up data.
Exclusion
- Patients with alternative diagnoses that mimic ALS (e.g., multifocal motor neuropathy, cervical myelopathy, myasthenia gravis).
- Absence of medical records
Key Trial Info
Start Date :
May 13 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2028
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT07143656
Start Date
May 13 2021
End Date
September 1 2028
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Biocells Medical
Warsaw, Poland